Sexually transmitted diseases · 2026
Treponemal and Lipoidal Immunoglobulin M Tests in the Diagnosis and Management of Syphilis Among Nonpregnant Adults: A Systematic Review.
Систематический обзорСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lorenz Zachary W, McCarthy Michael E, Tuddenham Susan, Hamill Matthew M, Manabe Yukari C, Ghanem Khalil G
Аннотация
BACKGROUND: There are many commercially available tests that isolate immunoglobulin M (IgM) antibodies to either treponemal-specific or lipoidal (non-treponemal) antigens. These IgM tests for syphilis are distinct from standard serologies that are routinely used (e.g., Treponema pallidum particle agglutination), most of which detect a combination of IgM and immunoglobulin G antibodies. There are several clinical scenarios where IgM tests for syphilis may be of clinical utility: in diagnosing early primary syphilis, in differentiating early from late latent syphilis, in detecting reinfections, and in identifying persons at increased risk for complications such as neurological syphilis.
METHODS: We performed a systematic review of IgM tests for syphilis among nonpregnant adults, focusing on these clinical scenarios.
RESULTS: Thirteen studies were included.
CONCLUSIONS: The current data suffer from limited sample sizes and significant heterogeneity in syphilis staging, IgM assays, and serological comparators. Whether IgM serologies offer additional clinical benefits beyond standard serologies is unclear. These tests should not be routinely used in the absence of higher-quality data.
METHODS: We performed a systematic review of IgM tests for syphilis among nonpregnant adults, focusing on these clinical scenarios.
RESULTS: Thirteen studies were included.
CONCLUSIONS: The current data suffer from limited sample sizes and significant heterogeneity in syphilis staging, IgM assays, and serological comparators. Whether IgM serologies offer additional clinical benefits beyond standard serologies is unclear. These tests should not be routinely used in the absence of higher-quality data.